Aethlon Medical, Inc. (AEMD) stock has fallen 14.29% over the past week and gets a Neutral rating from InvestorsObserver Sentiment Indicator.
Aethlon Medical, Inc. has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on AEMD!
What is Stock Sentiment?
Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends.
Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.
InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.
Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.
What's Happening With AEMD Stock Today?
Aethlon Medical, Inc. (AEMD) stock is trading at $0.96 as of 10:55 AM on Friday, Jun 17, a decline of -$0.05, or -4.48% from the previous closing price of $1.01. The stock has traded between $0.95 and $1.00 so far today. Volume today is low. So far 72,096 shares have traded compared to average volume of 601,716 shares.
To see InvestorsObserver's Sentiment Score for Aethlon Medical, Inc. click here.
More About Aethlon Medical, Inc.
Aethlon Medical Inc is a medical technology company. It is focused on addressing unmet needs in health and biodefense. The company operates through two segments namely Aethlon for therapeutic applications, which represents its therapeutic business activities and ESI for diagnostic applications which signifies diagnostic business activities. It is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and to eliminate life-threatening viruses from the circulatory system. The company generates revenue from Aethlon segment.
Click Here to get the full Stock Report for Aethlon Medical, Inc. stock.